Several studies have shown that loss of function, likely pathogenic mutations in either AMH or its receptor anti-Müllerian hormone receptor type II (AMHR2), are associated with the development of persistent Müllerian duct syndrome (PMDS) in humans and other mammals (10-12). Here, AMHR2 is linked to persistent Mullerian duct syndrome.